-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. SUPREME COURT RULES IN FAVOR OF GENERIC DRUGMAKER HIKMA IN 'SKINNY LABEL' PATENT DISPUTE OVER AMARIN HEART DRUG VASCEPA

Reuters·06/04/2026 14:01:22

Please log in to view news